Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome

Overview of attention for article published in Kidney International, June 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 2 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 100 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,864 followers.

@docthahir @kidney_boy @paulphel maybe we should ask to my friend @CorMur who was among the authors of this trial http://t.co/aKBMgaRsz7

@docthahir @kidney_boy @paulphel maybe we should ask to my friend @CorMur who was among the authors of this trial http://t.co/aKBMgaRsz7

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.